tiprankstipranks
Trending News
More News >
OnKure Therapeutics reports Q1 EPS ($1.19), consensus ($1.38)
PremiumThe FlyOnKure Therapeutics reports Q1 EPS ($1.19), consensus ($1.38)
1M ago
OnKure Therapeutics sees cash runway into 4Q26
Premium
The Fly
OnKure Therapeutics sees cash runway into 4Q26
1M ago
OnKure Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
OnKure Therapeutics initiated with an Outperform at Evercore ISI
1M ago
Onkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies
PremiumCompany AnnouncementsOnkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies
3M ago
OnKure Therapeutics Reports Progress and Financials
Premium
Company Announcements
OnKure Therapeutics Reports Progress and Financials
3M ago
OnKure Therapeutics price target lowered to $30 from $35 at Oppenheimer
Premium
The Fly
OnKure Therapeutics price target lowered to $30 from $35 at Oppenheimer
3M ago
OnKure Therapeutics announces safety, pharmacokinetic data on OKI-219
PremiumThe FlyOnKure Therapeutics announces safety, pharmacokinetic data on OKI-219
6M ago
OnKure Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
OnKure Therapeutics initiated with an Outperform at Leerink
6M ago
OnKure Therapeutics Reports Strategic Merger and Financial Updates
Premium
Company Announcements
OnKure Therapeutics Reports Strategic Merger and Financial Updates
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100